The panel advanced five bills aimed at speeding up Food and Drug Administration (FDA) approval of new drugs and devices. The measures will be combined with several other bills to become the Senate’s version of the House-passed 21st Century Cures Act.
But a crucial element of the bill still remains to be worked out: new funding for medical research at the National Institutes of Health (NIH), which Democrats have made a deal breaker.
Read Full Article »